Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax

Hematol Transfus Cell Ther. 2022 Jan-Mar;44(1):124-127. doi: 10.1016/j.htct.2021.01.004. Epub 2021 Mar 13.

¹ Institute of Biomedical Sciences, Universidade de Sao Paulo, Sao Paulo, SP, Brazil; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
² Institute of Biomedical Sciences, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
³ Hematology and Clinical Oncology, Ribeirão Preto Medical School, Universidade de Sao Paulo, Ribeirao Preto, Sao Paulo, SP, Brazil.
⁴ Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
⁵ Institute of Biomedical Sciences, Universidade de Sao Paulo, Sao Paulo, SP, Brazil. Electronic address: [email protected].

No abstract available

Publication types